CN101505777B - 含有来自金合欢属树皮的物质的肿瘤的预防和/或治疗用组合物 - Google Patents
含有来自金合欢属树皮的物质的肿瘤的预防和/或治疗用组合物 Download PDFInfo
- Publication number
- CN101505777B CN101505777B CN2006800555846A CN200680055584A CN101505777B CN 101505777 B CN101505777 B CN 101505777B CN 2006800555846 A CN2006800555846 A CN 2006800555846A CN 200680055584 A CN200680055584 A CN 200680055584A CN 101505777 B CN101505777 B CN 101505777B
- Authority
- CN
- China
- Prior art keywords
- acacia
- bark
- leukemic
- compositions
- manufacturing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 241000220479 Acacia Species 0.000 title claims abstract description 71
- 235000010643 Leucaena leucocephala Nutrition 0.000 title claims abstract description 71
- 239000000203 mixture Substances 0.000 title claims abstract description 56
- 206010028980 Neoplasm Diseases 0.000 title abstract description 42
- 239000000284 extract Substances 0.000 claims description 54
- 244000020998 Acacia farnesiana Species 0.000 claims description 50
- 235000003074 Acacia farnesiana Nutrition 0.000 claims description 50
- 239000000463 material Substances 0.000 claims description 38
- 238000004519 manufacturing process Methods 0.000 claims description 24
- 235000013305 food Nutrition 0.000 claims description 16
- 241001465754 Metazoa Species 0.000 claims description 15
- 241001199697 Acacia dealbata Species 0.000 claims description 14
- 239000003814 drug Substances 0.000 claims description 13
- 150000008442 polyphenolic compounds Chemical class 0.000 claims description 13
- 235000013824 polyphenols Nutrition 0.000 claims description 13
- 241000993444 Acacia mearnsii Species 0.000 claims description 7
- 230000037396 body weight Effects 0.000 claims description 7
- 229940079593 drug Drugs 0.000 claims description 6
- 235000018553 tannin Nutrition 0.000 claims description 6
- 229920001864 tannin Polymers 0.000 claims description 6
- 239000001648 tannin Substances 0.000 claims description 6
- 241000278701 Acacia mangium Species 0.000 claims description 5
- 235000017631 Acacia mangium Nutrition 0.000 claims description 5
- -1 flavanol compound Chemical class 0.000 claims description 4
- 244000236161 Acacia decurrens Species 0.000 claims description 3
- 240000001335 Acacia pycnantha Species 0.000 claims description 3
- 239000002537 cosmetic Substances 0.000 claims description 3
- 230000003203 everyday effect Effects 0.000 claims description 3
- CITFYDYEWQIEPX-UHFFFAOYSA-N Flavanol Natural products O1C2=CC(OCC=C(C)C)=CC(O)=C2C(=O)C(O)C1C1=CC=C(O)C=C1 CITFYDYEWQIEPX-UHFFFAOYSA-N 0.000 claims description 2
- 235000011987 flavanols Nutrition 0.000 claims description 2
- 239000004615 ingredient Substances 0.000 claims description 2
- 229920000642 polymer Polymers 0.000 claims description 2
- 238000012360 testing method Methods 0.000 description 56
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 34
- 239000000843 powder Substances 0.000 description 28
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 14
- 230000000259 anti-tumor effect Effects 0.000 description 14
- 238000002360 preparation method Methods 0.000 description 14
- 241000699670 Mus sp. Species 0.000 description 13
- 201000011510 cancer Diseases 0.000 description 13
- 235000011468 Albizia julibrissin Nutrition 0.000 description 11
- 210000004027 cell Anatomy 0.000 description 10
- 239000003826 tablet Substances 0.000 description 10
- 235000013361 beverage Nutrition 0.000 description 8
- 230000002265 prevention Effects 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- 230000000694 effects Effects 0.000 description 7
- 230000008859 change Effects 0.000 description 6
- 238000001035 drying Methods 0.000 description 6
- 210000000051 wattle Anatomy 0.000 description 6
- 101000981253 Mus musculus GPI-linked NAD(P)(+)-arginine ADP-ribosyltransferase 1 Proteins 0.000 description 5
- 241000700159 Rattus Species 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- 238000007670 refining Methods 0.000 description 5
- 206010006187 Breast cancer Diseases 0.000 description 4
- 208000026310 Breast neoplasm Diseases 0.000 description 4
- 201000008275 breast carcinoma Diseases 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 235000020188 drinking water Nutrition 0.000 description 4
- 239000003651 drinking water Substances 0.000 description 4
- 210000003038 endothelium Anatomy 0.000 description 4
- 239000002031 ethanolic fraction Substances 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- 238000007689 inspection Methods 0.000 description 4
- 208000032839 leukemia Diseases 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 238000001694 spray drying Methods 0.000 description 4
- 239000008399 tap water Substances 0.000 description 4
- 235000020679 tap water Nutrition 0.000 description 4
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 3
- 206010037660 Pyrexia Diseases 0.000 description 3
- 239000012980 RPMI-1640 medium Substances 0.000 description 3
- 238000009835 boiling Methods 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 238000002481 ethanol extraction Methods 0.000 description 3
- 239000012634 fragment Substances 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 239000008101 lactose Substances 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 239000013641 positive control Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 230000035755 proliferation Effects 0.000 description 3
- 230000004083 survival effect Effects 0.000 description 3
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 2
- 201000003076 Angiosarcoma Diseases 0.000 description 2
- 206010009944 Colon cancer Diseases 0.000 description 2
- 208000001333 Colorectal Neoplasms Diseases 0.000 description 2
- 208000001258 Hemangiosarcoma Diseases 0.000 description 2
- NWIBSHFKIJFRCO-WUDYKRTCSA-N Mytomycin Chemical compound C1N2C(C(C(C)=C(N)C3=O)=O)=C3[C@@H](COC(N)=O)[C@@]2(OC)[C@@H]2[C@H]1N2 NWIBSHFKIJFRCO-WUDYKRTCSA-N 0.000 description 2
- 206010038389 Renal cancer Diseases 0.000 description 2
- 208000006265 Renal cell carcinoma Diseases 0.000 description 2
- 208000005718 Stomach Neoplasms Diseases 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- 235000021185 dessert Nutrition 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- VFZYLYJWCROVLO-UHFFFAOYSA-N ent-Fisetidinol Natural products OC1CC2=CC=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 VFZYLYJWCROVLO-UHFFFAOYSA-N 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000013355 food flavoring agent Nutrition 0.000 description 2
- 206010017758 gastric cancer Diseases 0.000 description 2
- 210000004013 groin Anatomy 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 235000013402 health food Nutrition 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 239000002798 polar solvent Substances 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 201000010174 renal carcinoma Diseases 0.000 description 2
- 235000013599 spices Nutrition 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 201000011549 stomach cancer Diseases 0.000 description 2
- 238000007920 subcutaneous administration Methods 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 231100000820 toxicity test Toxicity 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- 235000007219 (+)-catechin Nutrition 0.000 description 1
- 229930013915 (+)-catechin Natural products 0.000 description 1
- CVOFKRWYWCSDMA-UHFFFAOYSA-N 2-chloro-n-(2,6-diethylphenyl)-n-(methoxymethyl)acetamide;2,6-dinitro-n,n-dipropyl-4-(trifluoromethyl)aniline Chemical compound CCC1=CC=CC(CC)=C1N(COC)C(=O)CCl.CCCN(CCC)C1=C([N+]([O-])=O)C=C(C(F)(F)F)C=C1[N+]([O-])=O CVOFKRWYWCSDMA-UHFFFAOYSA-N 0.000 description 1
- 244000301344 Acacia baileyana Species 0.000 description 1
- 241001327634 Agaricus blazei Species 0.000 description 1
- 102100027070 BH3-like motif-containing cell death inducer Human genes 0.000 description 1
- 206010005003 Bladder cancer Diseases 0.000 description 1
- 101100127890 Caenorhabditis elegans let-23 gene Proteins 0.000 description 1
- 208000017897 Carcinoma of esophagus Diseases 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 241000251730 Chondrichthyes Species 0.000 description 1
- 208000005243 Chondrosarcoma Diseases 0.000 description 1
- 241000190633 Cordyceps Species 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 101100381997 Danio rerio tbc1d32 gene Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 201000008808 Fibrosarcoma Diseases 0.000 description 1
- 206010053717 Fibrous histiocytoma Diseases 0.000 description 1
- 208000022072 Gallbladder Neoplasms Diseases 0.000 description 1
- 102100035695 Gamma-aminobutyric acid receptor-associated protein Human genes 0.000 description 1
- 240000001080 Grifola frondosa Species 0.000 description 1
- 235000007710 Grifola frondosa Nutrition 0.000 description 1
- 101000984516 Homo sapiens BH3-like motif-containing cell death inducer Proteins 0.000 description 1
- 101001001372 Homo sapiens Gamma-aminobutyric acid receptor-associated protein Proteins 0.000 description 1
- 208000002260 Keloid Diseases 0.000 description 1
- 206010023330 Keloid scar Diseases 0.000 description 1
- 206010023347 Keratoacanthoma Diseases 0.000 description 1
- 208000018142 Leiomyosarcoma Diseases 0.000 description 1
- 229920001491 Lentinan Polymers 0.000 description 1
- 206010024612 Lipoma Diseases 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 206010025219 Lymphangioma Diseases 0.000 description 1
- 206010025323 Lymphomas Diseases 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 101100381999 Mus musculus Tbc1d32 gene Proteins 0.000 description 1
- 206010030155 Oesophageal carcinoma Diseases 0.000 description 1
- 206010033128 Ovarian cancer Diseases 0.000 description 1
- 206010061535 Ovarian neoplasm Diseases 0.000 description 1
- 244000131316 Panax pseudoginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 206010061902 Pancreatic neoplasm Diseases 0.000 description 1
- 208000009565 Pharyngeal Neoplasms Diseases 0.000 description 1
- 206010034811 Pharyngeal cancer Diseases 0.000 description 1
- 241000123113 Phellinus igniarius Species 0.000 description 1
- 206010035226 Plasma cell myeloma Diseases 0.000 description 1
- 208000037062 Polyps Diseases 0.000 description 1
- 102100038280 Prostaglandin G/H synthase 2 Human genes 0.000 description 1
- 108050003267 Prostaglandin G/H synthase 2 Proteins 0.000 description 1
- 208000034541 Rare lymphatic malformation Diseases 0.000 description 1
- GMPPKSLKMRADRM-UHFFFAOYSA-N Robidanol Natural products OC1CC2=CC=C(O)C=C2OC1C1=CC(O)=C(O)C(O)=C1 GMPPKSLKMRADRM-UHFFFAOYSA-N 0.000 description 1
- 206010039491 Sarcoma Diseases 0.000 description 1
- 206010039796 Seborrhoeic keratosis Diseases 0.000 description 1
- 206010068771 Soft tissue neoplasm Diseases 0.000 description 1
- 208000021712 Soft tissue sarcoma Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 208000033781 Thyroid carcinoma Diseases 0.000 description 1
- 208000024770 Thyroid neoplasm Diseases 0.000 description 1
- 206010043966 Tongue neoplasm malignant stage unspecified Diseases 0.000 description 1
- 102000003425 Tyrosinase Human genes 0.000 description 1
- 108060008724 Tyrosinase Proteins 0.000 description 1
- 208000007097 Urinary Bladder Neoplasms Diseases 0.000 description 1
- 206010047675 Vocal cord polyp Diseases 0.000 description 1
- 208000033559 Waldenström macroglobulinemia Diseases 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 231100000460 acute oral toxicity Toxicity 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 208000020990 adrenal cortex carcinoma Diseases 0.000 description 1
- 208000007128 adrenocortical carcinoma Diseases 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000003005 anticarcinogenic agent Substances 0.000 description 1
- 230000009876 antimalignant effect Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 208000001119 benign fibrous histiocytoma Diseases 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 208000002458 carcinoid tumor Diseases 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 235000015218 chewing gum Nutrition 0.000 description 1
- 229940112822 chewing gum Drugs 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 208000024207 chronic leukemia Diseases 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 201000010305 cutaneous fibrous histiocytoma Diseases 0.000 description 1
- 208000035250 cutaneous malignant susceptibility to 1 melanoma Diseases 0.000 description 1
- 230000000254 damaging effect Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 201000005619 esophageal carcinoma Diseases 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 206010016629 fibroma Diseases 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 201000010175 gallbladder cancer Diseases 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000007903 gelatin capsule Substances 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000002489 hematologic effect Effects 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 210000001117 keloid Anatomy 0.000 description 1
- 201000005264 laryngeal carcinoma Diseases 0.000 description 1
- 229940115286 lentinan Drugs 0.000 description 1
- 210000000088 lip Anatomy 0.000 description 1
- 206010024627 liposarcoma Diseases 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 201000000564 macroglobulinemia Diseases 0.000 description 1
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 description 1
- 201000001441 melanoma Diseases 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 201000000050 myeloid neoplasm Diseases 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 208000018389 neoplasm of cerebral hemisphere Diseases 0.000 description 1
- 208000025189 neoplasm of testis Diseases 0.000 description 1
- 239000003605 opacifier Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 201000008968 osteosarcoma Diseases 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 208000008443 pancreatic carcinoma Diseases 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 208000022131 polyp of large intestine Diseases 0.000 description 1
- 208000014515 polyp of vocal cord Diseases 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 201000001514 prostate carcinoma Diseases 0.000 description 1
- 201000009410 rhabdomyosarcoma Diseases 0.000 description 1
- GMPPKSLKMRADRM-SWLSCSKDSA-N robinetinidol Chemical compound C1([C@H]2OC3=CC(O)=CC=C3C[C@@H]2O)=CC(O)=C(O)C(O)=C1 GMPPKSLKMRADRM-SWLSCSKDSA-N 0.000 description 1
- 201000003385 seborrheic keratosis Diseases 0.000 description 1
- 201000000849 skin cancer Diseases 0.000 description 1
- 201000008261 skin carcinoma Diseases 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000000528 statistical test Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 201000002510 thyroid cancer Diseases 0.000 description 1
- 208000013077 thyroid gland carcinoma Diseases 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
- 201000005112 urinary bladder cancer Diseases 0.000 description 1
- 208000012991 uterine carcinoma Diseases 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/30—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/111—Aromatic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
- C07D311/60—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with aryl radicals attached in position 2
- C07D311/62—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with aryl radicals attached in position 2 with oxygen atoms directly attached in position 3, e.g. anthocyanidins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Public Health (AREA)
- Food Science & Technology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Mycology (AREA)
- Botany (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Birds (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Nutrition Science (AREA)
- Dermatology (AREA)
- Molecular Biology (AREA)
- Physiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
摄取组 | 移植后第14天 | 移植后第28天 |
对照1组 | 13.1±3.93 | 23.8±5.29 |
试验1组 | 10.5±4.03(19.8)I | 19.6±3.92(17.6)I |
对照2组 | 12.2±0.84 | 22.0±2.74 |
试验2a组 | 13.0±1.15(-6.56)II | 24.8±1.50(-12.7)II |
对照3组 | 13.0±1.73 | 28.2±1.30 |
试验3a组 | 10.2±1.79(21.5)III | 20.6±2.97*(27.0)III |
阳性对照组 | 7.4±6.58(43.5)I | 14.0±6.12(41.2)I |
Claims (19)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/JP2006/315865 WO2008018140A1 (en) | 2006-08-10 | 2006-08-10 | Composition for preventing and/or treating tumor containing component originating in the bark of tree belonging to the genus acacia |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101505777A CN101505777A (zh) | 2009-08-12 |
CN101505777B true CN101505777B (zh) | 2012-05-30 |
Family
ID=39032685
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2006800555846A Active CN101505777B (zh) | 2006-08-10 | 2006-08-10 | 含有来自金合欢属树皮的物质的肿瘤的预防和/或治疗用组合物 |
Country Status (7)
Country | Link |
---|---|
US (1) | US8124137B2 (zh) |
EP (1) | EP2052730B1 (zh) |
KR (1) | KR101398737B1 (zh) |
CN (1) | CN101505777B (zh) |
AU (1) | AU2006347123B2 (zh) |
WO (1) | WO2008018140A1 (zh) |
ZA (1) | ZA200901647B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11173187B2 (en) * | 2018-11-13 | 2021-11-16 | Immortazyme Company Ltd. | Concentrated oil-based polyphenol composition and a method of producing the oil-based polyphenol composition |
Family Cites Families (45)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0425620Y2 (zh) | 1987-08-07 | 1992-06-19 | ||
JPH03287507A (ja) | 1990-04-05 | 1991-12-18 | Iwata Kagaku Kogyo Kk | 汚損生物防除剤及び汚損防止塗料組成物 |
JP3232137B2 (ja) | 1992-08-21 | 2001-11-26 | 丸善製薬株式会社 | 活性酸素消去剤 |
FR2710533A1 (fr) | 1993-09-29 | 1995-04-07 | Nemet Pierre Alain | Nouvelles applications de l'extrait d'écorce de Tepesco Huite dans le domaine de la cosmétologie ou de la dermatologie. |
JP2747206B2 (ja) | 1993-11-12 | 1998-05-06 | 神協産業株式会社 | 高血糖改善用組成物 |
JP3290291B2 (ja) | 1994-05-02 | 2002-06-10 | ポーラ化成工業株式会社 | 活性酸素消去剤及びこれを含む組成物 |
JP3532999B2 (ja) * | 1995-03-24 | 2004-05-31 | 株式会社ロッテ | 新規なタンニン類およびこれを有効成分とするリパーゼ阻害剤 |
KR19980702533A (ko) * | 1995-12-26 | 1998-07-15 | 도리이 신이찌로 | 프로시아니딘을 유효성분으로 하는 항비만제 |
JPH09291039A (ja) | 1995-12-26 | 1997-11-11 | Suntory Ltd | プロシアニジンを有効成分とする抗肥満剤 |
JPH1025238A (ja) | 1996-07-10 | 1998-01-27 | Mikimoto Pharmaceut Co Ltd | 皮膚外用剤 |
JP4831849B2 (ja) | 1997-04-23 | 2011-12-07 | 三省製薬株式会社 | 活性酸素消去剤およびその用途 |
JPH11180888A (ja) | 1997-12-24 | 1999-07-06 | Otsuka Pharmaceut Co Ltd | ヘリコバクター・ピロリ菌用の抗菌剤、感染予防剤および食品 |
JP2000044472A (ja) | 1998-07-30 | 2000-02-15 | Kikkoman Corp | 糖尿病性合併症の予防または治療薬剤 |
JP2000073056A (ja) | 1998-09-01 | 2000-03-07 | Sunstar Inc | 抗酸化性抽出物およびその製法 |
US20010024664A1 (en) | 1999-03-19 | 2001-09-27 | Obukowicz Mark G. | Selective COX-2 inhibition from edible plant extracts |
US6290993B1 (en) | 1999-07-23 | 2001-09-18 | E-L Management Corp. | Compositions containing mimosa phenolic compounds |
JP2001064172A (ja) | 1999-08-26 | 2001-03-13 | Kikkoman Corp | Apc遺伝子の変異に起因する疾患の予防・治療剤 |
JP2001098264A (ja) | 1999-09-30 | 2001-04-10 | Kobayashi Pharmaceut Co Ltd | 抗酸化剤及び活性酸素消去剤 |
JP2002010753A (ja) | 2000-04-24 | 2002-01-15 | Marukin Chuyu Co Ltd | オリーブ葉またはその抽出成分を含有するアミラーゼ阻害剤および高血糖者用食品 |
JP2002275076A (ja) | 2001-03-15 | 2002-09-25 | Toyo Shinyaku:Kk | 血糖上昇抑制剤および健康食品 |
JP2002051735A (ja) | 2001-06-26 | 2002-02-19 | Fancl Corp | 食品組成物 |
NZ515523A (en) * | 2001-11-15 | 2004-04-30 | Horticulture & Food Res Inst | Extraction of phenolic antioxidants |
US7108868B2 (en) * | 2002-03-22 | 2006-09-19 | Unigen Pharmaceuticals, Inc. | Isolation of a dual cox-2 and 5-lipoxygenase inhibitor from acacia |
JP2003313138A (ja) | 2002-04-23 | 2003-11-06 | Kanzu Kenkyu Kaihatsu:Kk | 痒みを抑制するための薬剤または機能性食品、及びその効果の評価方法 |
WO2003092599A2 (en) | 2002-04-30 | 2003-11-13 | Unigen Pharmaceuticals, Inc. | Formulation of a mixture of free-b-ring flavonoids and flavans as a therapeutic agent |
JP2003342185A (ja) | 2002-05-25 | 2003-12-03 | Bhn Kk | リパーゼ活性阻害剤 |
CN1246011C (zh) | 2002-06-07 | 2006-03-22 | 云南白药集团天然药物研究院 | 藕节提取物在制备改善人体胰岛素抵抗和治疗或预防肥胖症的药物中的应用 |
JP2004024054A (ja) | 2002-06-21 | 2004-01-29 | Makoto Fujii | フコイダン系健康食品 |
JP2004051513A (ja) * | 2002-07-18 | 2004-02-19 | Asahi Breweries Ltd | 抗腫瘍剤 |
JP2004075579A (ja) | 2002-08-13 | 2004-03-11 | Nippon Hypox Lab Inc | 外用鎮痒剤 |
JP4432069B2 (ja) | 2002-09-03 | 2010-03-17 | ビーエイチエヌ株式会社 | 肥満抑制剤 |
JP2004217559A (ja) | 2003-01-14 | 2004-08-05 | Maruhachi Muramatsu:Kk | 糖尿病態の予防・改善剤 |
BRPI0407893A (pt) | 2003-02-26 | 2006-03-01 | Unigen Pharmaceuticals Inc | formulação para uso na prevenção e tratamento de doenças e condições induzidas por carboidrato |
JP2004300117A (ja) | 2003-04-01 | 2004-10-28 | Rasheru Seiyaku Kk | 化粧料組成物 |
JP4495406B2 (ja) | 2003-04-21 | 2010-07-07 | 株式会社武蔵野免疫研究所 | センダングサ属植物抽出物含有組成物 |
JP4730642B2 (ja) | 2003-05-28 | 2011-07-20 | 株式会社mimozax | 活性酸素消去剤及びその組成物 |
GB0317020D0 (en) * | 2003-07-21 | 2003-08-27 | Sahajanand Biotech Private Ltd | Herbo-mineral formulation for refractory leukemias and lymphomas |
JP2005068081A (ja) | 2003-08-25 | 2005-03-17 | Asahi Breweries Ltd | 発癌予防剤 |
BRPI0414063A (pt) | 2003-09-02 | 2006-10-24 | Unigen Pharmaceuticals Inc | formulação de uma mistura de flavonóides de anel b livre e flavanos para uso na prevenção e tratamento de declìnio cognitivo e danos de memória relacionados à idade |
JP2005239559A (ja) | 2004-02-24 | 2005-09-08 | Nof Corp | ホスホリパーゼa2阻害剤 |
JP2006016330A (ja) | 2004-06-30 | 2006-01-19 | Suntory Ltd | 脂肪燃焼促進剤 |
JP4823538B2 (ja) | 2005-02-28 | 2011-11-24 | 株式会社mimozax | アカシア属樹皮由来物を含有する抗肥満組成物 |
JP5002127B2 (ja) | 2005-02-28 | 2012-08-15 | 株式会社mimozax | アカシア属樹皮由来物を含有する血糖降下組成物 |
US20060204599A1 (en) * | 2005-03-14 | 2006-09-14 | Wheat Jared R | Dietary supplement and method of using same |
KR20090023722A (ko) * | 2006-06-20 | 2009-03-05 | 메타프로테오믹스, 엘엘씨 | 테트라하이드로이소알파산 기본 단백질 키나제 변조 암 치료방법 |
-
2006
- 2006-08-10 KR KR1020097004927A patent/KR101398737B1/ko active IP Right Grant
- 2006-08-10 WO PCT/JP2006/315865 patent/WO2008018140A1/ja active Application Filing
- 2006-08-10 AU AU2006347123A patent/AU2006347123B2/en not_active Ceased
- 2006-08-10 US US12/376,895 patent/US8124137B2/en active Active
- 2006-08-10 CN CN2006800555846A patent/CN101505777B/zh active Active
- 2006-08-10 EP EP06782651.1A patent/EP2052730B1/en not_active Expired - Fee Related
-
2009
- 2009-03-09 ZA ZA2009/01647A patent/ZA200901647B/en unknown
Also Published As
Publication number | Publication date |
---|---|
CN101505777A (zh) | 2009-08-12 |
AU2006347123A1 (en) | 2008-02-14 |
AU2006347123B2 (en) | 2013-06-06 |
US20100178370A1 (en) | 2010-07-15 |
KR101398737B1 (ko) | 2014-05-27 |
EP2052730A1 (en) | 2009-04-29 |
KR20090057007A (ko) | 2009-06-03 |
EP2052730B1 (en) | 2016-03-23 |
ZA200901647B (en) | 2010-02-24 |
EP2052730A4 (en) | 2012-03-21 |
WO2008018140A1 (en) | 2008-02-14 |
US8124137B2 (en) | 2012-02-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR102509966B1 (ko) | 한약 추출물을 포함하는 교모세포종 예방 또는 치료용 조성물 | |
CN101983072A (zh) | 矿物质吸收促进剂和缺铁性贫血改善剂或食物组合物 | |
CN101505775B (zh) | 含有来自金合欢属树皮的物质的抗氧化组合物 | |
CN107530315A (zh) | 肌肉细胞中的能量代谢激活剂 | |
CN108014150A (zh) | 天然药物组合物在制备抗缺氧和抗辐射的药物或食品中的应用 | |
CN101505776B (zh) | 含有来自金合欢属树皮的物质的抗肥胖组合物 | |
CN101505777B (zh) | 含有来自金合欢属树皮的物质的肿瘤的预防和/或治疗用组合物 | |
KR100883566B1 (ko) | 신품종 고구밸리 감자를 이용한 암 예방을 위한건강기능식품 | |
Abdellatef et al. | Antiproliferative action of Moringa oleifera Lam. root extracts in acute myeloid leukemia (AML) cell line | |
Pandey et al. | Review on nutritional profile of Medicago sativa seeds | |
CN101505774B (zh) | 含有来自金合欢属树皮的物质的搔痒预防和/或治疗用组合物 | |
KR20210147247A (ko) | 좁은잎천선과 혼합 추출물을 유효성분으로 함유하는 면역 증진용 조성물 | |
KR101508561B1 (ko) | 귀리를 포함하는 혼합 생약재 추출물을 함유하는 당뇨병의 예방 또는 치료용 약학조성물 | |
CN101505778B (zh) | 含有来自金合欢属树皮的物质的降血糖组合物 | |
KR102517944B1 (ko) | 복방 한방 추출물을 유효성분으로 함유하는 암의 예방 또는 치료용 약학적 조성물 및 건강 기능 식품 | |
KR102154145B1 (ko) | 연 추출물을 유효성분으로 함유하는 암의 예방 또는 치료용 약학적 조성물 및 건강 기능 식품 | |
KR102380291B1 (ko) | 풀무치 추출물을 포함하는 비만 예방 또는 치료용 조성물 | |
KR101959735B1 (ko) | 잇꽃씨 추출물을 유효성분으로 포함하는 대장암에 대한 시스플라틴의 항암활성 증진용 조성물 | |
KR20200098311A (ko) | 한약 추출물을 포함하는 교모세포종 예방 또는 치료용 조성물 | |
KR20180116904A (ko) | 황칠나무 유래 나노입자를 포함하는 암 예방 또는 치료용 약학적 조성물 | |
WO2006129901A1 (en) | Anticancer agent, food and manufacturing method of anticancer agent and food | |
JP5016200B2 (ja) | アカシア属樹皮由来物を含有する腫瘍の予防及び/又は治療用組成物 | |
KR20220086870A (ko) | 목이버섯 추출물을 유효성분으로 포함하는 골다공증 예방 또는 치료용 조성물 | |
KR20220133573A (ko) | 도깨비고비 추출물을 유효성분으로 포함하는 항암 조성물 | |
KR20140086240A (ko) | 말뱅이나물 종자 추출물의 유효성분을 포함하는 항암제 조성물 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: MIMOZAX CO., LTD. Free format text: FORMER OWNER: WOOD ONE CO LTD (JP) Effective date: 20110517 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20110517 Address after: Hiroshima County, Japan Applicant after: MIMOZAX Co., Ltd. Address before: Hiroshima County, Japan Applicant before: WOODONE Co., Ltd. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CP01 | Change in the name or title of a patent holder |
Address after: Hiroshima County, Japan Patentee after: Acacia-No-Ki Co., Ltd. Address before: Hiroshima County, Japan Patentee before: MIMOZAX Co., Ltd. |
|
CP01 | Change in the name or title of a patent holder |